On the preparation of a therapeutic dose of 177Lu-labeled DOTA–TATE using indigenously produced 177Lu in medium flux reactor
Author:
Publisher
Elsevier BV
Subject
Radiation
Reference28 articles.
1. 177Lu–DOTA–lanreotide: a novel tracer as a targeted agent for tumor therapy;Banerjee;Nucl. Med. Biol.,2004
2. Radio-labeled receptor-binding peptides: a new class of radiopharmaceuticals;Boerman;Semin. Nucl. Med.,2000
3. Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives;Breeman;Eur. J. Nucl. Med.,2001
4. Optimising conditions for radiolabelling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities;Breeman;Eur. J. Nucl. Med. Mol. Imag.,2003
5. Towards the goal of cancer specific imaging and therapy;Britton;Nucl. Med. Commun.,1997
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Need for enrichment of lutetium isotope and design of a laser based separator module;Applied Radiation and Isotopes;2023-12
2. Preparation of Patient Doses of [177Lu]Lu-DOTATATE and [177Lu]Lu-PSMA-617 with Carrier Added (CA) and No Carrier Added (NCA) 177Lu;Nuclear Medicine and Molecular Imaging;2022-10-07
3. Clinical Dose Preparation of [177Lu]Lu-DOTA-Pertuzumab Using Medium Specific Activity [177Lu]LuCl3 for Radioimmunotherapy of Breast and Epithelial Ovarian Cancers, with HER2 Receptor Overexpression;Cancer Biotherapy and Radiopharmaceuticals;2022-06-01
4. Dosimetric analyses of intra-arterial versus standard intravenous administration of 177Lu-DOTATATE in patients of well differentiated neuroendocrine tumor with liver-dominant metastatic disease;The British Journal of Radiology;2021-10-01
5. Therapeutic Multidose Preparation of a Ready-to-Use 177Lu-PSMA-617 Using Carrier Added Lutetium-177 in a Hospital Radiopharmacy and Its Clinical Efficacy;Cancer Biotherapy and Radiopharmaceuticals;2021-10-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3